Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Differences in DMT treatment experiences among people with MS: Here’s what patients say

July 30, 2018

For many people living with multiple sclerosis (MS), treatment decisions can often be nuanced and complicated. In April of 2018, the American Academy of Neurology (AAN) released new guidelines about when to begin, change, and end disease-modifying therapies (DMTs) for MS patients. MS In America 2018 results may help the healthcare industry gain a broader understanding of people’s experiences, or lack thereof, with DMTs and other MS treatment options.

WHITEPAPER DOWNLOAD: #authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities

June 28, 2018

Download the full free whitepaper, "#authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities"

Expanding Patient Voices and Understanding Their Perspectives

Patient Centricity Starts With Patients: Closing the Trial Recruitment Gap

June 27, 2018

There is a lot of talk in the industry about patient centricity, but is it the reality? We talk about putting the needs of patients first and keeping them central in the business decisions we make across the healthcare industry. However, as we discussed on a panel at this year’s DIA 2018 Global Annual Meeting, somehow in the effort to amplify patient centricity, a critical voice is often underrepresented—the voice of the patient.

Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease

June 1, 2018

A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.

From Refineries to Resilience: How Health Union’s New COO, Steve Warker, Plans to Drive Alignment, Efficiency, and Innovation

November 24, 2025

New COO Steve Warker shares his strategic vision for driving innovation, alignment, and responsible AI adoption across Health Union.

Two hands holding a comment bubble with a heart, surrounded by comment bubbles

Fostering Safe Conversations: Health Union’s Moderation Model for Trust and Brand Safety

November 21, 2025

Learn how Health Union’s human-centered moderation model, rooted in empathy and psychological concepts, keeps members safe and protects your brand.

How Health Union Navigates Market Research in the Age of AI

November 17, 2025

A Health Union poll of nearly 6,000 patients (across 49 conditions) and 105 healthcare providers explored their attitudes toward emerging AI in health management. Learn the critical findings and how Health Union’s research model ensures humanity remains core to its insights.

More Than Moderators: Why Authentic Expertise is the Core of Our Community Model

November 13, 2025

Health Union’s Community Managers don’t just manage discussion forums, they nurture a thriving, condition-specific ecosystem where validation and understanding empower patients and caregivers.

Healthcare Industry Thought Leadership

Contact